newsfilter
← Latest News
Business Wire·

Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30

Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that second quarter of fiscal year 2025 financial results will be